Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    "Intrauterine infections"
Show Display Options
Rank Status Study
1 Recruiting Study of Antiretroviral Therapy to Prevent HBV Intrauterine Infection
Condition: Hepatitis B, Chronic
Interventions: Drug: Tenofovir1;   Drug: Tenofovir2;   Drug: Tenofovir3;   Drug: Tenofovir4
2 Unknown  The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection
Condition: Maternal-fetal Transmission of Cytomegalovirus During Pregnancy
3 Completed Prevention for Mother-to-infant Transmission of HBV
Condition: HBV
Intervention: Drug: Hepatitis B immunoglobulin
4 Terminated Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity
Conditions: Bacterial Vaginosis;   Premature Birth;   Sepsis;   Periventricular Leukomalacia;   Bronchopulmonary Dysplasia
Intervention: Drug: Lactobacillus rhamnosus GR1 and Lactobacillus reuteri RC-14

Indicates status has not been verified in more than two years